3136 results for «3084»
3136 results
Unusual cases of PFO closure
15 May 2024 – From EuroPCR 2024
This session will feature selected EuroPCR 2024 Clinical Case submissions focused on unusual cases of patent foramen ovale (PFO) closure. Attendees will have the opportunity to explore challenging cases, such as unexplained hypoxemia in an elderly man post-lung cancer lobectomy, a case of persistent dyspnea and...
Personalised Vascular Care Award - Competition
16 May 2024 – From EuroPCR 2024
This session features a competition for the Personalised Vascular Care Award, showcasing selected abstracts on various aspects of personalised vascular care. The presentations cover topics such as the evaluation of myocardial bridges, the relationship between IMR and FFR, the use of contrast-derived indices of coronary microvascular...
PCI in challenging coronary anatomies
15 May 2024 – From EuroPCR 2024
This session explores various complex PCI cases, providing insights and solutions for navigating challenging coronary anatomies. The discussions cover techniques for crossing difficult paths, the role of PCI as a backup for CABG, and the use of specialized tools like balloons and rotablation when standard approaches...
TAVI: procedural complications - Part 2
16 May 2024 – From EuroPCR 2024
This session focuses on the management of procedural complications during transcatheter aortic valve implantation (TAVI). It presents a series of challenging cases, including valve-in-valve TAVI with complications, acute cardiogenic shock during valve-in-valve TAVI, and various other complications such as left ventricular perforation, fistula formation, and lost...
Challenging situations to access the aortic valve - Part 2
15 May 2024 – From EuroPCR 2024
This session features a series of selected EuroPCR 2024 Clinical Case submissions, showcasing various challenging scenarios encountered during transcatheter aortic valve interventions. Experts will present and discuss cases involving transbrachial TAVI, TAVI on a porcelain aorta, transcaval access, and other complex access approaches, providing valuable insights...
Left main imaging
16 May 2024 – From EuroPCR 2024
This session focuses on the use of intracoronary imaging techniques, such as OCT and IVUS, in the management of complex left main coronary artery disease. It presents various case studies, including successful complex PCI of left main trifurcation, left main compression due to pulmonary hypertension, and...
Abstracts from the Call for submissions - Nurses and Allied Professionals
16 May 2024 – From EuroPCR 2024
This session features selected abstracts from the call for submissions, focusing on the contributions of nurses and allied health professionals in the field of interventional cardiology. The presentations cover topics such as patient experience in the TAVI process, insights into the use of intravascular imaging and...
Different procedural techniques for the treatment of heavily calcified coronary lesions
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions focused on the management of heavily calcified coronary lesions. Experts will present and discuss various techniques, including the use of artificial intelligence-generated coronary CT angiography for PCI guidance, advanced calcium mapping with coronary CT, orbital atherectomy, and...
Acute coronary syndromes
16 May 2024 – From EuroPCR 2024
This session, in collaboration with various cardiology societies, focuses on the management of acute coronary syndromes (ACS). It presents three case studies, covering the management of culprit lesions in ACS, tips and tricks in difficult situations, and the management of multivessel disease. The discussions aim to...
Second generation biolimus drug-coated balloon in clinical practice
15 May 2024 – From EuroPCR 2024
Discover the potential applications of the new biolimus-coated balloon in treating de novo large vessel lesions, explore its effectiveness in addressing ISR based on findings from the BIO ASCEND ISR study, and uncover insights into the safety and feasibility of BA9 DCB in treating small vessel,...
The future of interventional cardiology imaging
15 May 2024 – From EuroPCR 2024
Explore this session to discover the latest innovations in interventional cardiology images, including the benefits of artificial intelligence and angio-CT in PCI/SHD procedures. Learn about Alphenix Evolve and the initial experiences with AI imaging in daily cathlab practice, alongside intraprocedural angio-CT guided LAAO, and engage in...
PCI in patients with diabetes: next generation DES + DCB stent platform in action
14 May 2024 – From EuroPCR 2024
Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...
Sirolimus-coated balloon: exploring the case- and clinical-based evidences
16 May 2024 – From EuroPCR 2024
Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...
Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions
15 May 2024 – From EuroPCR 2024
Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...
Identification and treatment of (sub)clinical transcatheter valve thrombosis
16 May 2024 – From EuroPCR 2024
This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...
PASCAL Precision system simulation showcase: grasp the difference!
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, explore a transcatheter edge-to-edge mitral valve repair case, delve into discussions backed by simulation, evidence, and real-world cases to understand atraumatic clasp and closure techniques and predictable implant release. Additionally, gain insights into real-world evidence for tricuspid TEER from the EuroTR trial...
Mitral TEER challenges and complications
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, highlighting the challenges and complications associated with mitral transcatheter edge-to-edge repair (TEER) procedures. Attendees will have the opportunity to engage in discussions and learn from the experiences shared by the presenters, covering...
Restoring vessel physiology drives outcomes - The Bioadaptor experience
16 May 2024 – From EuroPCR 2024
Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...
